KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xylem (XYL) Shares Outstanding (Diluted Average) (2016 - 2026)

Xylem has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $243.4 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) changed 0.16% year-over-year to $243.4 million; the TTM value through Mar 2026 reached $243.4 million, changed 0.16%, while the annual FY2025 figure was $244.0 million, 0.19% changed from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $243.4 million at Xylem, roughly flat from $244.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $244.1 million in Q3 2025 and troughed at $180.8 million in Q2 2022.
  • A 5-year average of $220.7 million and a median of $243.0 million in 2024 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): dropped 0.39% in 2022 and later soared 34.03% in 2024.
  • Year by year, Shares Outstanding (Diluted Average) stood at $181.0 million in 2022, then grew by 20.57% to $218.2 million in 2023, then rose by 11.6% to $243.5 million in 2024, then grew by 0.19% to $244.0 million in 2025, then dropped by 0.24% to $243.4 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for XYL at $243.4 million in Q1 2026, $244.0 million in Q4 2025, and $244.1 million in Q3 2025.